INSULIN-LIKE GROWTH FACTOR TYPE I PROTEIN BOUND - ANVISA Registration 81325990141

Access comprehensive regulatory information for INSULIN-LIKE GROWTH FACTOR TYPE I PROTEIN BOUND in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81325990141 and manufactured by ACRO BIOTECH INC.. The registration is held by QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including MEDIX BIOCHEMICA, DIAGNOSTICS BIOCHEM CANANDA INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81325990141
Registration Details
ANVISA Registration Number: 81325990141
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Família Cassete de Teste Rápido de iGFBP-1 (Secreção Vaginal)
Risk Class II

Registration Details

81325990141

25351268448202021

19933144000129

Company Information

ACRO BIOTECH INC.
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Nov 05, 2020

VIGENTE

09/18/2025 19:00:01